Breastfeeding
Every manufacturer places this the same way.
scroll for all 13 products →
| Section | Zydus Pharmaceuticals UK Ltd1mg Oral Solution | Viatris (formerly Mylan or Upjohn)10mg Tablets | Ipca Laboratories UK Ltd10mg Tablets | Dr. Reddy's Laboratories (UK) Ltd10mg Tablets | Flamingo Pharma (UK) Ltd10mg Tablets | Sandoz Limited10mg Tablets | Amarox Limited10mg Tablet | Aurobindo Pharma - Milpharm Ltd.10mg Tablets | Rosemont Pharmaceuticals Limited1mg Oral Solution | Amarox Limited5mg Tablets | Sandoz Limited5mg Tablets | Zentiva2.5mg Tablets | Viatris (formerly Mylan or Upjohn)10mg Tablets |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ContraindicatedThe label says it must not be used. | |||||||||||||
| WarningThe label says it can be used, with care. | |||||||||||||
| InteractionThe label says another medicine affects it. | |||||||||||||
| PregnancyThe label gives advice for pregnancy or breastfeeding. | Pregnancy | Pregnancy | Pregnancy | Pregnancy | Pregnancy | Pregnancy | Pregnancy | Pregnancy | Pregnancy | Pregnancy | Pregnancy | Pregnancy | Pregnancy |
| ExcipientThe label lists it as an ingredient, not a restriction. |
- Pregnancy
321–335 of 1121 characters Viatris (formerly Mylan or Upjohn)
322–336 of 1126 characters 321–335 of 1121 characters Dr. Reddy's Laboratories (UK) Ltd
320–334 of 1122 characters 321–335 of 1121 characters 321–335 of 1123 characters 321–335 of 1121 characters Aurobindo Pharma - Milpharm Ltd.
323–337 of 1128 characters Rosemont Pharmaceuticals Limited
325–339 of 1199 characters 321–335 of 1121 characters 321–335 of 1123 characters 320–334 of 1120 characters Viatris (formerly Mylan or Upjohn)
321–335 of 1121 characters
ty was observed at high doses (see section 5.3). Use in pregnancy is only recommended when there is no safer alternative and when the disease itself carries greater risk for the mother and foetus. Breast-feeding Amlodipine is excreted in human milk. The proportion of the maternal dose received by the infant has been estimated with an interquartile range of 3–7%, with a maximum of 15%. The effect of amlodip
Identical in all 13 labels. Surrounding text shown from Zydus Pharmaceuticals UK Ltd.